Autologous hematopoietic cell transplantation as a part of a sequential multi-phase therapeutic approach (R-COPADM/CYVE/ASCT) as first-line treatment of high-grade B-cell lymphoma: results of a retrospective study with long-term follow-up.
- DOI
- 10.1038/s41409-022-01902-4
- Published
- 2023 Apr
- Container
- Bone marrow transplantation
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41409-022-01902-4,
title = {Autologous hematopoietic cell transplantation as a part of a sequential multi-phase therapeutic approach (R-COPADM/CYVE/ASCT) as first-line treatment of high-grade B-cell lymphoma: results of a retrospective study with long-term follow-up.},
author = {Alsuliman T and Stocker N and Corre E and Dulery R and Sestili S and Ricard L and Malard F and Mohty M and Coppo P and Marjanovic Z},
year = {2023},
journal = {Bone marrow transplantation},
doi = {10.1038/s41409-022-01902-4},
url = {https://doi.org/10.1038/s41409-022-01902-4}
}RIS
TY - JOUR TI - Autologous hematopoietic cell transplantation as a part of a sequential multi-phase therapeutic approach (R-COPADM/CYVE/ASCT) as first-line treatment of high-grade B-cell lymphoma: results of a retrospective study with long-term follow-up. AU - Alsuliman T AU - Stocker N AU - Corre E AU - Dulery R AU - Sestili S AU - Ricard L AU - Malard F AU - Mohty M AU - Coppo P AU - Marjanovic Z PY - 2023 JO - Bone marrow transplantation DO - 10.1038/s41409-022-01902-4 UR - https://doi.org/10.1038/s41409-022-01902-4 ER -
APA
T, A., N, S., E, C., R, D., S, S., L, R., F, M., M, M., P, C., & Z, M. (2023). Autologous hematopoietic cell transplantation as a part of a sequential multi-phase therapeutic approach (R-COPADM/CYVE/ASCT) as first-line treatment of high-grade B-cell lymphoma: results of a retrospective study with long-term follow-up.. Bone marrow transplantation. https://doi.org/10.1038/s41409-022-01902-4
Source records
- pubmed · retrieved 2026-09-25T08:51:53.890Z